Abstract
Human sural nerve fascicles from healthy volunteers and patients with inherited hypertrophic neuropathy (HMSN-I and HMSN-III, respectively) and with Friedreich ataxia (FA) were transplanted into nude and T-cell-suppressed mouse nerve to determine whether transplanted Schwann cells would express the histologic and myelination abnormalities characteristic of these disorders. Sections above, at, and below the transplant were evaluated by phase and transmission electronmicroscope (TEM) morphometric analysis at times up to 3 months after transplant. The characteristic structure of the human perineurium and of the onion-bulb formation was maintained, indicating that human Schwann and perineurial cells survive transplantation and express themselves. Myelination in human nerve xenografts was delayed as compared to distal mouse nerve myelination, which may reflect genetic characteristics, delayed vascularization, or physical size of the transplant. A variable number of fibers regrew outside the fascicle, creating a problem in data interpretation, since differences may exist in populations of fibers to be compared in control and disease xenografts and in xenografts and distal mouse nerve. Although xenograft myelination began earlier in controls than in HMSN-III, the difference in myelination at 3 months was not significantly different, nor was there a significant difference in onset or degree of myelination in controls, HMSN-I, and FA nerve xenografts at intervals up to 3 months. Lack of significant differences, especially for HMSN-III and control nerves, may be attributed to small numbers and insufficient time after transplant. A study of more xenografts, harvested after longer periods of time, will thus be needed before concluding that Schwann cells play no major role in the hypomyelination of HMSN-III. Present evidence does not favor a major role of Schwann cells in the segmental demyelination of HMSN I and FA.
- © 1978 by the American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
